Castleark Management’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-65,310
Closed -$1.59M 290
2022
Q3
$1.59M Buy
+65,310
New +$2.25M 0.09% 169
2022
Q1
Sell
-95,899
Closed -$5.67M 333
2021
Q4
$5.67M Buy
95,899
+6,305
+7% +$436K 0.21% 116
2021
Q3
$5.96M Buy
+89,594
New +$5.53M 0.23% 110
2019
Q4
Sell
-135,550
Closed -$2.22M 353
2019
Q3
$2.22M Buy
+135,550
New +$2.72M 0.09% 206

Other funds holding CYRX

Castleark Management's CYRX Position: Q4 2022 in Review

Castleark Management sold out of CryoPort (CYRX) in Q4 2022, closing a stake of 65,310 shares — an estimated $1.59M sold.

Castleark Management first reported a position in CYRX in Q3 2019 and held it in 4 quarters. The position peaked at $5.96M in Q3 2021. 171 funds tracked by Wall St. Rank hold CYRX as of Q4 2022.

  • Castleark Management reported no remaining CryoPort position as of Q4 2022 after selling out during the quarter.
  • Castleark Management sold 65,310 CryoPort shares in Q4 2022, an estimated $1.59M.
  • Castleark Management first reported a position in CryoPort in Q3 2019 and held it in 4 quarters.
  • Castleark Management's CryoPort position peaked at $5.96M in Q3 2021.
  • 171 funds tracked by Wall St. Rank held CryoPort as of Q4 2022.

Based on Castleark Management's 13F filing for Q4 2022, filed 10 Feb 2023.